These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 8557329)

  • 1. A patient-derived cytotoxic T-lymphocyte clone and two peptide-dependent monoclonal antibodies recognize HLA-B27-peptide complexes with low stringency for peptide sequences.
    Huang F; Hermann E; Wang J; Cheng XK; Tsai WC; Wen J; Kuipers JG; Kellner H; Ackermann B; Roth G; Williams KM; Yu DK; Raybourne RB
    Infect Immun; 1996 Jan; 64(1):120-7. PubMed ID: 8557329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The association of HLA-B27 binding peptide and spondylarthropathies].
    Huang F; Yü D
    Zhonghua Yi Xue Za Zhi; 1998 May; 78(5):385-7. PubMed ID: 10923447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cross-reactive T cell clones from unrelated individuals reveal similarities in peptide presentation between HLA-B27 and HLA-DR2.
    López D; Barber DF; Villadangos JA; López de Castro JA
    J Immunol; 1993 Apr; 150(7):2675-86. PubMed ID: 7681078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure and diversity of HLA-B27-specific T cell epitopes. Analysis with site-directed mutants mimicking HLA-B27 subtype polymorphism.
    Calvo V; Rojo S; López D; Galocha B; López de Castro JA
    J Immunol; 1990 May; 144(10):4038-45. PubMed ID: 1692072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA-B27 subtype polymorphism and CTL epitope choice: studies with EBV peptides link immunogenicity with stability of the B27:peptide complex.
    Brooks JM; Colbert RA; Mear JP; Leese AM; Rickinson AB
    J Immunol; 1998 Nov; 161(10):5252-9. PubMed ID: 9820497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of mutant beta 2-microglobulins on the conformation of HLA-B27 detected by antibody and by CTL.
    Fukazawa T; Hermann E; Edidin M; Wen J; Huang F; Kellner H; Floege J; Farahmandian D; Williams KM; Yu DT
    J Immunol; 1994 Oct; 153(8):3543-50. PubMed ID: 7930576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro mutagenesis of HLA-B27. Amino acid substitutions at position 67 disrupt anti-B27 monoclonal antibody binding in direct relation to the size of the substituted side chain.
    el-Zaatari FA; Sams KC; Taurog JD
    J Immunol; 1990 Feb; 144(4):1512-7. PubMed ID: 1689355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A monoclonal antibody that recognizes HLA-B27 in the context of peptides.
    Wang J; Yu DT; Fukazawa T; Kellner H; Wen J; Cheng XK; Roth G; Williams KM; Raybourne RB
    J Immunol; 1994 Feb; 152(3):1197-205. PubMed ID: 8301124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Limited diversity of peptides related to an alloreactive T cell epitope in the HLA-B27-bound peptide repertoire results from restrictions at multiple steps along the processing-loading pathway.
    Paradela A; Alvarez I; García-Peydró M; Sesma L; Ramos M; Vázquez J; López De Castro JA
    J Immunol; 2000 Jan; 164(1):329-37. PubMed ID: 10605027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum antibodies from patients with ankylosing spondylitis and Reiter's syndrome are reactive with HLA-B27 cells transfected with the Mycobacterium tuberculosis hsp60 gene.
    Kellner H; Wen J; Wang J; Raybourne RB; Williams KM; Yu DT
    Infect Immun; 1994 Feb; 62(2):484-91. PubMed ID: 7905462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clonal heterogeneity in LFA-3 and ICAM-1 requirement for lysis by alloreactive T lymphocytes.
    Galocha B; López D; López de Castro JA
    J Immunol; 1993 Mar; 150(5):1653-62. PubMed ID: 7679690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 707-AP peptide recognized by human antibody induces human leukocyte antigen A2-restricted cytotoxic T lymphocyte killing of melanoma.
    Takahashi T; Irie RF; Nishinaka Y; Hoon DS
    Clin Cancer Res; 1997 Aug; 3(8):1363-70. PubMed ID: 9815820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of HLA-B27-restricted peptides from the Chlamydia trachomatis proteome with possible relevance to HLA-B27-associated diseases.
    Kuon W; Holzhütter HG; Appel H; Grolms M; Kollnberger S; Traeder A; Henklein P; Weiss E; Thiel A; Lauster R; Bowness P; Radbruch A; Kloetzel PM; Sieper J
    J Immunol; 2001 Oct; 167(8):4738-46. PubMed ID: 11591805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peptide binding to HLA-A2 and HLA-B27 isolated from Escherichia coli. Reconstitution of HLA-A2 and HLA-B27 heavy chain/beta 2-microglobulin complexes requires specific peptides.
    Parker KC; Carreno BM; Sestak L; Utz U; Biddison WE; Coligan JE
    J Biol Chem; 1992 Mar; 267(8):5451-9. PubMed ID: 1544922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequence constraints and recognition by CTL of an HLA-B27-restricted HIV-1 gag epitope.
    Nietfield W; Bauer M; Fevrier M; Maier R; Holzwarth B; Frank R; Maier B; Riviere Y; Meyerhans A
    J Immunol; 1995 Mar; 154(5):2189-97. PubMed ID: 7868892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Avidity dictates the lytic capacity of human cytolytic T lymphocyte clones with similar fine specificity against murine cells expressing HLA-B27 antigen.
    Calvo V; Rojo S; Aparicio P; Galocha B; López de Castro JA
    J Immunol; 1988 Dec; 141(11):3798-803. PubMed ID: 2460549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and immunogenicity of HLA-B27 in high-transfection recipient P815: a new method to induce monoclonal antibodies directed against HLA-B27.
    Thurau SR; Wildner G; Kuon W; Weiss EH; Riethmüller G
    Tissue Antigens; 1989 May; 33(5):511-9. PubMed ID: 2508265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of the substitution of critical residues on the allorecognition of HLA-B27.
    Ozen S; Clayberger C; Krensky AM; Benjamin R
    Clin Exp Rheumatol; 1992; 10(6):583-7. PubMed ID: 1282853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel HLA-B27 allele maps B27 allospecificity to the region around position 70 in the alpha 1 domain.
    Choo SY; Fan LA; Hansen JA
    J Immunol; 1991 Jul; 147(1):174-80. PubMed ID: 1711072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross-reactivity among evolutionarily distant major histocompatibility complex class I molecules (HLA-B27 and H-2Kk) revealed by xenoreactive T lymphocytes.
    Frangoulis B; Reboul M; Rocca A; Pla M
    Eur J Immunol; 1993 Feb; 23(2):338-42. PubMed ID: 8436169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.